Settlement for amount owing by CCM Marketing Sdn Bhd (CCMM) to Chemical Company of Malaysia Berhad (CCMB) of RM204,665,784 by way of transfer to CCMB 204,665,784 ordinary shares in the share capital of CCM Duopharma Biotech Berhad (CCMD) owned by CCMM, a wholly owned subsidiary of CCMB, in CCMD pursuant to the Debt Settlement Agreement entered into between CCMM and CCMB dated 11 August 2017.
Upon the fulfillment of all the conditions precedent of the Debt Settlement Agreement dated 11 August 2017 including the receipt of the approval of the SC exempting CCMB from the obligation to undertake the Mandatory Offer 1 vide its letter dated 29 August 2017, the transfer of 204,665,784 CCMD Shares from CCMM to CCMB arising from the Debt Settlement Agreement has been completed on 25 September 2017. Hence the the direct shareholding of CCMM in CCMD has now ceased.